Wastewater samples have shown elevated levels of a respiratory virus that has been linked to paralysis in some children, ...

Health officials are reminding the public that antibiotics are ineffective against respiratory infections caused by viruses, ...

It's that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modeling study ...

Respiratory virus data included in the interactive data application is up-to-date as of September 14, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

HealthDay News — For older adults, respiratory syncytial virus (RSV) vaccination is effective ... Diya Surie, MD, from the US Centers for Disease Control and Prevention in Atlanta, and ...

RSV, or respiratory syncytial virus ... If the virus moves into the lungs, it can cause coughing and wheezing, and turn into a severe respiratory disease, such as bronchiolitis – inflammation ...

You will be able to get a free RSV vaccination because you’re aged 75 to 79 years (or recently turned 80). Every year, thousands of people in your age group need hospital care for RSV infection. RSV ...